Zami Aberman Insider Trading $AISF PLURISTEM THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Zami Aberman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Zami Aberman. Zami Aberman is CEO & Chairman in PLURISTEM THERAPEUTICS INC ($AISF) and Co-CEO & Chairman in PLURISTEM THERAPEUTICS INC ($AISF) and Executive Chairman in PLURISTEM THERAPEUTICS INC ($AISF) and President and CEO in PLURISTEM THERAPEUTICS INC ($AISF).
Zami Aberman in PLURISTEM THERAPEUTICS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Zami Aberman: Executive Chairman, Co-CEO & Chairman, CEO & Chairman, President and CEO
Holdings: 993,973 shares
Latest Transaction: Sep 10 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Zami Aberman in PLURISTEM THERAPEUTICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10 2020 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | Executive Chairman | Grant | A | 0.00 | 500,000 | 0 | 1,493,973 | 994 K to 1.5 M (+50.30 %) |
| Sep 10 2020 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | Executive Chairman | Grant | A | 0.00 | 500,000 | 0 | 993,973 | 494 K to 994 K (+101.22 %) |
| Apr 08 2019 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | Co-CEO & Chairman | Option Exercise | P | 0.70 | 71,429 | 50,000 | 71,429 | |
| Apr 08 2019 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | Co-CEO & Chairman | Buy | P | 0.70 | 71,429 | 50,000 | 4,939,727 | 4.9 M to 4.9 M (+1.47 %) |
| Dec 20 2018 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | Co-CEO & Chairman | Grant | A | 0.00 | 250,000 | 0 | 4,868,298 | 4.6 M to 4.9 M (+5.41 %) |
| Dec 20 2018 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | Co-CEO & Chairman | Grant | A | 0.00 | 300,000 | 0 | 4,618,298 | 4.3 M to 4.6 M (+6.95 %) |
| Jun 23 2017 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | Co-CEO & Chairman | Grant | A | 0.00 | 2,000,000 | 0 | 4,318,298 | 2.3 M to 4.3 M (+86.27 %) |
| Dec 29 2016 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 200,000 | 0 | 2,318,298 | 2.1 M to 2.3 M (+9.44 %) |
| Feb 24 2016 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 1.33 | 5,000 | 6,650 | 111,400 | 106.4 K to 111.4 K (+4.70 %) |
| Feb 17 2016 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 1.06 | 6,000 | 6,360 | 106,400 | 100.4 K to 106.4 K (+5.98 %) |
| Feb 17 2016 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 1.07 | 9,000 | 9,630 | 100,400 | 91.4 K to 100.4 K (+9.85 %) |
| Feb 16 2016 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 0.80 | 31,000 | 24,716 | 91,400 | 60.4 K to 91.4 K (+51.32 %) |
| Jan 07 2016 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 150,000 | 0 | 2,118,298 | 2 M to 2.1 M (+7.62 %) |
| Nov 17 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 1.49 | 9,900 | 14,751 | 60,400 | 50.5 K to 60.4 K (+19.60 %) |
| Sep 21 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.10 | 14,000 | 29,400 | 50,500 | 36.5 K to 50.5 K (+38.36 %) |
| Sep 21 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.12 | 11,500 | 24,380 | 36,500 | 25 K to 36.5 K (+46.00 %) |
| Sep 16 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.15 | 5,000 | 10,750 | 25,000 | 20 K to 25 K (+25.00 %) |
| Sep 16 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.13 | 10,000 | 21,300 | 20,000 | 10 K to 20 K (+100.00 %) |
| Sep 16 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Buy | P | 2.07 | 10,000 | 20,700 | 10,000 | 0 to 10 K |
| Jun 30 2015 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | CEO & Chairman | Grant | A | 0.00 | 200,000 | 0 | 1,968,298 | 1.8 M to 2 M (+11.31 %) |
| Jan 18 2006 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | President and CEO | Option Exercise | A | 0.10 | 4,500,000 | 450,000 | 4,500,000 | |
| Jan 18 2006 | AISF | PLURISTEM THERAPEU ... | Aberman Zami | President and CEO | Buy | P | 0.10 | 3,000 | 297 | 3,000 | 0 to 3 K |
Page: 1